HRD test your advanced ovarian cancer patients at diagnosis to inform treatment decisions. 1,8-12 Earlier testing may support clinical management of advanced ovarian cancer and allows decisions to be personalised. Testing should be completed on the first available tissue, from biopsy (if one has been performed) or tissue from primary surgery.